Compare ORN & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORN | BWAY |
|---|---|---|
| Founded | 1994 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.4M | 337.9M |
| IPO Year | 2007 | 2019 |
| Metric | ORN | BWAY |
|---|---|---|
| Price | $11.11 | $23.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $11.25 | ★ $23.50 |
| AVG Volume (30 Days) | ★ 202.4K | 115.0K |
| Earning Date | 03-03-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 213.09 |
| EPS | ★ 0.24 | 0.13 |
| Revenue | ★ $835,917,000.00 | $49,094,000.00 |
| Revenue This Year | $6.40 | $330.76 |
| Revenue Next Year | $3.28 | $22.24 |
| P/E Ratio | ★ $46.68 | $73.11 |
| Revenue Growth | 7.02 | ★ 27.08 |
| 52 Week Low | $4.64 | $7.84 |
| 52 Week High | $11.90 | $24.84 |
| Indicator | ORN | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 63.95 | 71.27 |
| Support Level | $10.44 | $22.73 |
| Resistance Level | $11.00 | $24.84 |
| Average True Range (ATR) | 0.45 | 1.10 |
| MACD | 0.09 | 0.19 |
| Stochastic Oscillator | 82.20 | 73.44 |
Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.